Zimmer Historical Income Statement
| ZBH Stock | USD 112.02 1.38 1.25% |
Historical analysis of Zimmer Biomet income statement accounts such as Depreciation And Amortization of 999.3 M, Interest Expense of 141.5 M, Selling General Administrative of 2 B or Total Revenue of 5 B can show how well Zimmer Biomet Holdings performed in making a profits. Evaluating Zimmer Biomet income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Zimmer Biomet's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Zimmer Biomet Holdings latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Zimmer Biomet Holdings is a good buy for the upcoming year.
Zimmer |
About Zimmer Income Statement Analysis
Zimmer Biomet Holdings Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Zimmer Biomet shareholders. The income statement also shows Zimmer investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Zimmer Biomet Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Zimmer Biomet Holdings generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Zimmer Biomet Holdings minus its cost of goods sold. It is profit before Zimmer Biomet operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Zimmer Biomet Holdings. It is also known as Zimmer Biomet overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Zimmer Biomet's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Zimmer Biomet Holdings current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. As of now, Zimmer Biomet's Income Tax Expense is decreasing as compared to previous years. The Zimmer Biomet's current Non Recurring is estimated to increase to about 410.1 M, while Interest Expense is projected to decrease to under 141.5 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 4.9B | 4.9B | 5.3B | 3.6B | Total Revenue | 6.8B | 6.9B | 7.4B | 5.0B |
Zimmer Biomet income statement Correlations
Click cells to compare fundamentals
Zimmer Biomet Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Zimmer Biomet income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 171.9K | 1.0B | 937.7M | 926.4M | 951.7M | 999.3M | |
| Interest Expense | 226.9M | 212M | 208.4M | 164.8M | 201.2M | 141.5M | |
| Selling General Administrative | 3.3B | 3.2B | 3.3B | 2.8B | 2.8B | 2.0B | |
| Total Revenue | 8.0B | 7.0B | 6.8B | 6.9B | 7.4B | 5.0B | |
| Gross Profit | 5.7B | 4.9B | 4.9B | 4.9B | 5.3B | 3.6B | |
| Other Operating Expenses | 6.7B | 6.3B | 5.8B | 5.7B | 6.1B | 3.9B | |
| Operating Income | 1.1B | 723.3M | 860.3M | 1.1B | 1.3B | 853.0M | |
| Ebit | 2.3B | (63M) | 1.2B | 1.3B | 1.3B | 1.3B | |
| Research Development | 449.3M | 372M | 435.8M | 406M | 458.7M | 259.0M | |
| Ebitda | 2.3B | 969.7M | 2.2B | 2.2B | 2.2B | 1.6B | |
| Cost Of Revenue | 2.3B | 2.1B | 2.0B | 2.0B | 2.1B | 1.4B | |
| Total Operating Expenses | 4.5B | 4.2B | 3.9B | 3.7B | 4.0B | 2.5B | |
| Income Before Tax | 905.8M | (274.4M) | 499M | 403.5M | 1.1B | 1.1B | |
| Net Income | 1.1B | (137.4M) | 401.6M | 231.4M | 1.0B | 580.9M | |
| Income Tax Expense | (225.7M) | (137M) | 53.5M | 112.3M | 42.2M | 66.9M | |
| Net Income Applicable To Common Shares | 1.1B | (138.9M) | 401.6M | 231.4M | 266.1M | 252.8M | |
| Total Other Income Expense Net | (231.7M) | (357.5M) | (361.3M) | (292.8M) | (210.4M) | (220.9M) | |
| Extraordinary Items | 315M | 5M | (30.1M) | (58.8M) | (52.9M) | (50.3M) | |
| Net Income From Continuing Ops | 1.1B | (137.4M) | 402.1M | 291.2M | 475.2M | 445.5M | |
| Non Recurring | 70.1M | 645M | 16.3M | 292.8M | 336.7M | 410.1M | |
| Non Operating Income Net Other | (4.8M) | 25.4M | (153.3M) | (128M) | (115.2M) | (109.4M) | |
| Tax Provision | (225.7M) | (137M) | 16.3M | 112.3M | 232.8M | 244.4M | |
| Interest Income | 237.9M | 212M | 208.4M | 164.8M | 189.5M | 148.5M | |
| Net Interest Income | (226.9M) | (212M) | (208.4M) | (164.8M) | (193.5M) | (203.2M) | |
| Reconciled Depreciation | 1.0B | 1.0B | 1.1B | 926.4M | 939M | 808.5M |
Currently Active Assets on Macroaxis
When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.597 | Dividend Share 0.96 | Earnings Share 5.24 | Revenue Per Share 37.006 | Quarterly Revenue Growth 0.04 |
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.